Published in J Psychiatry Neurosci on May 01, 2015
Structural MRI Differences between Patients with and without First Rank Symptoms: A Delusion? Front Psychiatry (2015) 0.75
A History of Psychosis in Bipolar Disorder is Associated With Gray Matter Volume Reduction. Schizophr Bull (2016) 0.75
Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci (2005) 16.18
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet (2007) 11.27
Specification of cerebral cortical areas. Science (1988) 10.01
Reliability of MRI-derived measurements of human cerebral cortical thickness: the effects of field strength, scanner upgrade and manufacturer. Neuroimage (2006) 7.14
Some comments on frequently used multiple endpoint adjustment methods in clinical trials. Stat Med (1997) 4.58
The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry (1992) 4.54
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ (2002) 3.06
Handedness, language lateralisation and anatomical asymmetry in schizophrenia: meta-analysis. Br J Psychiatry (2001) 2.74
How does your cortex grow? J Neurosci (2011) 2.57
Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gen Psychiatry (1994) 2.06
Sex differences in schizophrenia. Int Rev Psychiatry (2010) 1.96
From the ventral to the dorsal striatum: devolving views of their roles in drug addiction. Neurosci Biobehav Rev (2013) 1.88
Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophr Bull (1990) 1.84
Brain morphological changes and early marijuana use: a magnetic resonance and positron emission tomography study. J Addict Dis (2000) 1.63
Systematic meta-review and quality assessment of the structural brain alterations in schizophrenia. Neurosci Biobehav Rev (2012) 1.60
Grey matter alterations associated with cannabis use: results of a VBM study in heavy cannabis users and healthy controls. Neuroimage (2011) 1.41
Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models. Br J Pharmacol (2010) 1.33
Cortical volume, surface area, and thickness in schizophrenia and bipolar disorder. Biol Psychiatry (2012) 1.32
The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample. Schizophr Bull (2010) 1.32
Reduced cortical thickness as an outcome of differential sensitivity to environmental risks in schizophrenia. Biol Psychiatry (2010) 1.32
Prefrontal cortex morphometry in abstinent adolescent marijuana users: subtle gender effects. Addict Biol (2009) 1.29
Cannabis and schizophrenia: results of a follow-up study. Eur Arch Psychiatry Clin Neurosci (1999) 1.27
Unique developmental trajectories of cortical thickness and surface area. Neuroimage (2013) 1.25
The association between regular cannabis exposure and alterations of human brain morphology: an updated review of the literature. Curr Pharm Des (2014) 1.25
Long-term effects of cannabis on brain structure. Neuropsychopharmacology (2014) 1.23
Cannabis and first-episode psychosis: different long-term outcomes depending on continued or discontinued use. Schizophr Bull (2009) 1.17
Cannabis use and the mental health of young people. Aust N Z J Psychiatry (2006) 1.13
Structural MRI findings in long-term cannabis users: what do we know? Subst Use Misuse (2010) 1.11
Diminished gray matter in the hippocampus of cannabis users: possible protective effects of cannabidiol. Drug Alcohol Depend (2010) 1.08
Cannabis use and brain structural alterations in first episode schizophrenia--a region of interest, voxel based morphometric study. Schizophr Res (2008) 1.07
Precipitation and determination of the onset and course of schizophrenia by substance abuse--a retrospective and prospective study of 232 population-based first illness episodes. Schizophr Res (2002) 1.06
Cerebral asymmetry: a quantitative, multifactorial, and plastic brain phenotype. Twin Res Hum Genet (2012) 1.05
Cannabis and schizophrenia: impact on onset, course, psychopathology and outcomes. Eur Arch Psychiatry Clin Neurosci (2002) 1.03
A selective review of volumetric and morphometric imaging in schizophrenia. Curr Top Behav Neurosci (2010) 1.02
Greater white and grey matter changes associated with early cannabis use in adolescent-onset schizophrenia (AOS). Schizophr Res (2011) 0.98
Current smoking and reduced gray matter volume-a voxel-based morphometry study. Neuropsychopharmacology (2014) 0.93
Anterior cingulate grey-matter deficits and cannabis use in first-episode schizophrenia. Br J Psychiatry (2007) 0.93
Smoking status as a potential confounder in the study of brain structure in schizophrenia. J Psychiatr Res (2013) 0.92
Cannabis, cannabinoids and schizophrenia: integration of the evidence. Aust N Z J Psychiatry (2008) 0.92
Regional specificity of sex effects on subcortical volumes across the lifespan in healthy aging. Hum Brain Mapp (2012) 0.92
Cannabis use and progressive cortical thickness loss in areas rich in CB1 receptors during the first five years of schizophrenia. Eur Neuropsychopharmacol (2010) 0.89
Can cortical thickness asymmetry analysis contribute to detection of at-risk mental state and first-episode psychosis? A pilot study. Radiology (2009) 0.89
Alteration to hippocampal shape in cannabis users with and without schizophrenia. Schizophr Res (2012) 0.89
Parietal lobe volume deficits in adolescents with schizophrenia and adolescents with cannabis use disorders. J Am Acad Child Adolesc Psychiatry (2011) 0.88
Cannabis abuse and brain morphology in schizophrenia: a review of the available evidence. Eur Arch Psychiatry Clin Neurosci (2012) 0.88
Comorbid substance abuse and brain morphology in recent-onset psychosis. Eur Arch Psychiatry Clin Neurosci (2009) 0.87
Cerebellar grey-matter deficits, cannabis use and first-episode schizophrenia in adolescents and young adults. Int J Neuropsychopharmacol (2011) 0.87
Gray matter volume differences and the effects of smoking on gray matter in schizophrenia. Schizophr Res (2007) 0.87
The brain effects of cannabis in healthy adolescents and in adolescents with schizophrenia: a systematic review. Psychiatry Res (2013) 0.86
Cigarette smoking and progressive brain volume loss in schizophrenia. Eur Neuropsychopharmacol (2010) 0.84
Effects of cannabis and familial loading on subcortical brain volumes in first-episode schizophrenia. Eur Arch Psychiatry Clin Neurosci (2013) 0.84
Cannabis and brain morphology in recent-onset schizophrenia. Schizophr Res (2004) 0.84
Age at onset of non-affective psychosis in relation to cannabis use, other drug use and gender. Psychol Med (2012) 0.82
Cannabis use and brain structural alterations of the cingulate cortex in early psychosis. Psychiatry Res (2013) 0.81
Increased striatal gray matter densities in patients with schizophrenia and substance use disorder: a voxel-based morphometry study. Psychiatry Res (2007) 0.81
Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings. Psychol Med (2011) 0.80
Combined grey matter VBM and white matter TBSS analysis in young first episode psychosis patients with and without cannabis consumption. Brain Topogr (2013) 0.78
Increased gray matter density in patients with schizophrenia and cannabis use: a voxel-based morphometric study using DARTEL. Schizophr Res (2012) 0.77